ALDER BIOPHARMACEUTICALS, INC. 15,000,000 Shares of Common Stock Underwriting AgreementAlder Biopharmaceuticals Inc • July 14th, 2017 • Pharmaceutical preparations • New York
Alder BioPharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom Leerink Partners LLC and Wells Fargo Securities, LLC are acting as representatives (the “Representatives”), an aggregate of 15,000,000 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 2,250,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
